Why CareDx Stock Soared Today

CareDx stock surged over 22% after reporting strong Q3 2026 earnings with 39% revenue growth to $139 million, driven by a 65% jump in testing services revenue and 51% increase in testing volumes. The company raised its full-year revenue guidance to $525 million (38% growth) and boosted adjusted EBITDA targets to $90-100 million, reflecting growing clinical interest in precision medicine diagnostics.